MARA Schedules Conference Call for Second Quarter 2024 Financial Results
July 18, 2024 08:05 ET
|
Marathon Digital Holdings Inc.
Earnings Webcast and Conference Call Set for Thursday, August 1, 2024 at 5:00 p.m. ET Fort Lauderdale, FL, July 18, 2024 (GLOBE NEWSWIRE) -- MARA (NASDAQ: MARA) ("MARA" or the "Company"), a global...
Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment
July 03, 2024 09:00 ET
|
Autonomix Medical, Inc.
Dr. Robert Schwartz, Chief Medical Officer of Autonomix, discusses preliminary positive results from the first five “lead-in” patients in the Company’s ongoing human clinical trial THE...
Global Tech Industries Group, Inc. Reaffirms Commitment to Shareholder Value and Continued Vigilance Against Noncompliant Trading Activities
June 14, 2024 09:25 ET
|
Global Tech Industries Group, Inc.
New York, NY, June 14, 2024 (GLOBE NEWSWIRE) -- (OTC: GTII) Global Tech Industries Group, Inc. (“GTII” or “The Company”), www.gtii-us.com, announced today that GTII’s management is taking steps in...
Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer
May 23, 2024 09:15 ET
|
Autonomix Medical, Inc.
Results from the preclinical study demonstrated statistically significant reduction of metastases and statistically significant reduction in tumor mass Lori Bisson, Chief Executive Officer...
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series
May 14, 2024 16:15 ET
|
Autonomix Medical, Inc.
Live webcast on Thursday, May 16th at 4:00 PM ET THE WOODLANDS, TX, May 14, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company...
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity
February 23, 2024 08:50 ET
|
Autonomix Medical, Inc.
Live webcast with Lori Bisson, Chief Executive Officer of Autonomix, on Thursday, February 29th at 12:00 PM ET THE WOODLANDS, TX, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:...
Autonomix Medical, Inc. Completes Transaction for Exclusive Worldwide Rights to Technology for Cardiology Field Use
January 30, 2024 09:05 ET
|
Autonomix Medical, Inc.
Autonomix now wholly owns development and commercialization rights to its technology in all indications Re-acquisition broadens Autonomix’s development and strategic opportunities THE WOODLANDS,...
Autonomix Medical, Inc. Announces Closing of $11.2 Million in Gross Proceeds from Initial Public Offering
January 26, 2024 16:05 ET
|
Autonomix Medical, Inc.
Shares to begin trading on NASDAQ on January 29, 2024 under the ticker symbol “AMIX” THE WOODLANDS, TX., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the...
Autonomix Medical, Inc. Completes Formation of Engineering Development Team and Provides Project Update
January 11, 2024 10:00 ET
|
Autonomix Medical, Inc.
Appointment of Marco Bedoya, a proven leader in medical device mechanical engineering, as Director of Product Development Engagements secured with preeminent firms to drive design and development...
Autonomix Medical, Inc. to Participate in the Virtual Investor Fireside Chat
December 14, 2023 10:15 ET
|
Autonomix Medical, Inc.
Live moderated video webcast on Tuesday, December 19th at 3:00 PM ET THE WOODLANDS, TX, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (“Autonomix” or the “Company”) a medical device...